₹271.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Viloresp 100/25 Pulmicaps belongs to the class of medicines called respiratory stimulants. It treats asthma and chronic obstructive pulmonary diseases (COPD). Asthma is a severe long-term health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. Symptoms may include shortness of breath or wheezing (whistling sound while breathing). COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. Viloresp 100/25 Pulmicaps helps reduce symptoms of asthma and COPD.
Viloresp 100/25 Pulmicaps contains Fluticasone Furoate (an inhaled corticosteroid) and Vilanterol (long-acting beta-agonists—LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate inhibits the release of certain chemicals in the body that cause inflammatory reactions, thus providing relief from sneezing, shortness of breath, or wheezing.
Viloresp 100/25 Pulmicaps is for inhalation use only. It should be used as your doctor advises. Your doctor will recommend the dose and duration of medicine based on your condition. Viloresp 100/25 Pulmicaps may cause specific side effects such as sore throat, sneezing, headache, cough, low fever, chest tightness, stuffy nose, a fungal infection in the mouth, nausea, stomach upset, dizziness, nervousness, or vomiting. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Viloresp 100/25 Pulmicaps should be avoided if you are allergic to any of its components. This medicine should be avoided in patients with life-threatening conditions of asthma or COPD. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, or kidney/liver problems or take any immunosuppressant medicines before taking this medicine. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Viloresp 100/25 Pulmicaps . If you experience severe difficulty breathing or wheezing while using Viloresp 100/25 Pulmicaps , please consult your doctor immediately so that alternative medicine may be prescribed. Viloresp 100/25 Pulmicaps is not recommended for children below 12 years of age.
Viloresp 100/25 Pulmicaps is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). The detailed uses of Viloresp 100/25 Pulmicaps are as follows:
Viloresp 100/25 Pulmicaps is a combination medicine that contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Viloresp 100/25 Pulmicaps also helps reduce exacerbations in patients suffering from COPD.
Consult your doctor
It is unknown whether Viloresp 100/25 Pulmicaps will interact with alcohol. It is advised to avoid or limit consumption of alcohol while on treatment with this medicine.
Caution
Limited data is available on the effect of Viloresp 100/25 Pulmicaps in pregnancy. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Viloresp 100/25 Pulmicaps . Your doctor may prescribe this medicine if the benefits outweigh the risks.
Caution
It is unknown whether Viloresp 100/25 Pulmicaps passes through breastmilk or not. Hence, if you are breastfeeding, inform your doctor before taking Viloresp 100/25 Pulmicaps . Your doctor may prescribe this medicine if the benefits outweigh the risks.
Not applicable
Viloresp 100/25 Pulmicaps usually does not affect your ability to drive or operate machinery.
Caution
Use Viloresp 100/25 Pulmicaps with caution, especially if you have a history of liver disease. Your doctor will weigh the benefits and risks before prescribing this medicine.
Caution
Use Viloresp 100/25 Pulmicaps with caution, especially if you have a history of kidney disease. Your doctor will weigh the benefits and risks before prescribing this medicine.
Unsafe
Viloresp 100/25 Pulmicaps is not recommended for children below 18 years as the safety and effectiveness were not established. Please consult your doctor.
Caution
Let your doctor know if you have any history of heart diseases before using Viloresp 100/25 Pulmicaps .
Consult your doctor
Please consult a doctor if you have any concerns regarding the use of Viloresp 100/25 Pulmicaps in elderly patients.

Have a query?
Viloresp 100/25 Pulmicaps should be avoided if you are allergic to any of its components. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, kidney/liver disease, or if you are taking any immunosuppressant medicines, as it can lead to serious infections. Regular monitoring of potassium levels and blood sugar levels is recommended while taking Viloresp 100/25 Pulmicaps . If you are pregnant or breastfeeding, inform your doctor before starting treatment with Viloresp 100/25 Pulmicaps . Sometimes, this medicine may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing or wheezing, please consult a doctor immediately so that alternative medicine may be prescribed. Viloresp 100/25 Pulmicaps is not recommended for children below 12 years of age.
Drug-Drug Interactions: Viloresp 100/25 Pulmicaps may interact with bronchodilators (salbutamol, aminophylline, theophylline), steroids (budesonide, prednisone, mometasone, beclomethasone), heart-related medicines (sotalol, digoxin, disopyramide, procainamide, quinidine), drugs used to lower high blood pressure (atenolol, metoprolol, propranolol), medicines to induce labour (oxytocin), antithyroid agent (levothyroxine), antidepressants (imipramine, amitriptyline, isocarboxazid, phenelzine), antifungals (itraconazole, ketoconazole), HIV medicines (atazanavir, ritonavir, nelfinavir, indinavir, cobicistat, saquinavir) and antiparkinson drug (levodopa).
Drug-Food Interactions: Viloresp 100/25 Pulmicaps may interact with grapefruit and grapefruit juice. Therefore, avoid intake of grapefruit or its juice with Viloresp 100/25 Pulmicaps as it may lead to severe adverse effects.
Drug-Disease Interactions: If you have high blood pressure, diabetes, chest or lung infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Viloresp 100/25 Pulmicaps .
Login/Sign Up
Login/Sign Up
RXMankind Pharma Pvt Ltd
₹381.5
(₹12.72 per unit)
RXGene Lifecare
₹208
(₹13.87 per unit)
RXLupin Ltd
₹180.5
(₹18.05 per unit)
Viloresp 100/25 Pulmicaps is used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD).
Viloresp 100/25 Pulmicaps is a combination of Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions.
Yes, Viloresp 100/25 Pulmicaps may cause fungal infection in the mouth in some patients. Hence, to avoid such side effects, brush your teeth or rinse your mouth with water after using Viloresp 100/25 Pulmicaps every time.
No, it is not recommended to take more than the prescribed dose of medicine as it can lead to serious adverse effects and worsen your health condition.
No, it is always recommended to inform your doctor or healthcare professional before stopping the treatment. Sudden stopping of medicine may cause your symptoms and worsen the condition.
Disclaimer
We provide you with authentic, trustworthy and relevant information